International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain.
Saved in:
| Title: | International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain. |
|---|---|
| Authors: | Berraondo P; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Edificio CIMA, Avenida Pio XII 55, 31008, Pamplona, Spain. pberraondol@unav.es.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. pberraondol@unav.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. pberraondol@unav.es., Aznar MA; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Edificio CIMA, Avenida Pio XII 55, 31008, Pamplona, Spain., Perez-Ruiz E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Edificio CIMA, Avenida Pio XII 55, 31008, Pamplona, Spain.; Division of Medical Oncology, Hospital Costa del Sol, Marbella, Spain., Rodriguez-Ruiz ME; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Edificio CIMA, Avenida Pio XII 55, 31008, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Castañon E; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Perez-Gracia JL; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Melero I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Edificio CIMA, Avenida Pio XII 55, 31008, Pamplona, Spain. imelero@unav.es.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. imelero@unav.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. imelero@unav.es.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain. imelero@unav.es. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2018 Nov; Vol. 67 (11), pp. 1809-1813. Date of Electronic Publication: 2018 Sep 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30182281 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Berraondo+P%22">Berraondo P</searchLink>; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Edificio CIMA, Avenida Pio XII 55, 31008, Pamplona, Spain. pberraondol@unav.es.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. pberraondol@unav.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. pberraondol@unav.es.<br /><searchLink fieldCode="AU" term="%22Aznar+MA%22">Aznar MA</searchLink>; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Edificio CIMA, Avenida Pio XII 55, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Perez-Ruiz+E%22">Perez-Ruiz E</searchLink>; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Edificio CIMA, Avenida Pio XII 55, 31008, Pamplona, Spain.; Division of Medical Oncology, Hospital Costa del Sol, Marbella, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Ruiz+ME%22">Rodriguez-Ruiz ME</searchLink>; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Edificio CIMA, Avenida Pio XII 55, 31008, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Castañon+E%22">Castañon E</searchLink>; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Perez-Gracia+JL%22">Perez-Gracia JL</searchLink>; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Melero+I%22">Melero I</searchLink>; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Edificio CIMA, Avenida Pio XII 55, 31008, Pamplona, Spain. imelero@unav.es.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. imelero@unav.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. imelero@unav.es.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain. imelero@unav.es. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2018 Nov; Vol. 67 (11), pp. 1809-1813. <i>Date of Electronic Publication: </i>2018 Sep 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30182281 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00262-018-2240-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1809 Titles: – TitleFull: International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Berraondo P – PersonEntity: Name: NameFull: Aznar MA – PersonEntity: Name: NameFull: Perez-Ruiz E – PersonEntity: Name: NameFull: Rodriguez-Ruiz ME – PersonEntity: Name: NameFull: Castañon E – PersonEntity: Name: NameFull: Perez-Gracia JL – PersonEntity: Name: NameFull: Melero I IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2018 Nov Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1432-0851 Numbering: – Type: volume Value: 67 – Type: issue Value: 11 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |